Komori
Kitazato (368A) · InitiativeFirst statedLatest Other Disclosures (2026-08-03): "Advanced"

Expansion into adjacent fields, including testing and healthcare, pharmaceuticals, in vitro diagnostics, and AI

First written in FY2026. 4 of 6 entries say "Advanced", first in 2026-06-24. Latest entry: 2026-08-03.

6entries
1years
5from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvanced2026-06-25 – 2026-08-032026: 62026
Same theme, other companies
Expansion into Medical IT, Community Healthcare and Drug Discovery SupportA theme 8 companies write about · 0 as a headwind · 9 as a tailwind

5 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  2. FY2026First statedAnnual report

    「We will expand into adjacent fields surrounding reproductive medicine by leveraging the technologies, expertise and customer base developed in the reproductive medicine field. Specifically, in addition to expanding existing adjacent businesses, such as testing and healthcare, we will explore business opportunities in new technology fields, including pharmaceuticals, in vitro diagnostics and AI, and work to create medium- to long-term growth opportunities.」

    In addition to its existing inspection and healthcare businesses, the Company clearly states for the first time that it is exploring opportunities to expand into pharmaceuticals, in vitro diagnostics, AI and other areas.
Moved together

"Overseas expansion focused on Europe, the United States, China and India" moved the same way as this thread, in the same document, in 2 of its 5 moves.

2★1
  1. ★This thread
  2. 1Overseas expansion focused on Europe, the United States, China and India2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Kitazato's next results are scheduled for 2026-10-28. Read the earnings preview It last moved in the Other Disclosures of 2026-08-03: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expansion into adjacent fields, including testing and healthcare, pharmaceuticals, in vitro diagnostics, and AI | Kitazato Corporation (368A) | Komori